Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Inspire Pharmaceuticals

1993 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
4 FINANCING ROUNDS
Description

Provider of discovery, development, and commercialization services for prescription biopharmaceutical products. The company focuses on treatments for various respiratory and ocular diseases caused by malfunctioning P2 receptors. It markets two eye products, Elestat, which treats allergic conjunctivitis, and Restasis, which treats dry eye disease.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 8081 Arco Corporate Drive
  • Suite 400
  • Raleigh, NC 27617
  • United States

+1 (919) 000-0000

Inspire Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Inspire Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Inspire Pharmaceuticals Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Inspire Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Inspire Pharmaceuticals Executive Team (9)

Name Title Board
Seat
Contact
Info
Kenneth Frazier JD President & Chief Executive Officer

8 Former Executives

You’re viewing 1 of 9 executives. Get the full list »

Inspire Pharmaceuticals Board Members (3)

Name Representing Role Since Contact
Info
0000000 000 00. Self Chairman 000 0000

2 Former Board Members

You’re viewing 1 of 3 board members. Get the full list »